Trial Profile
The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Fulvestrant (Primary) ; Goserelin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms PROOF
- 20 Mar 2014 New trial record